← Evidence map

ArticleAnnals of translational medicine2020

Cutting down on lung cancer: Ecliptasaponin A is a novel therapeutic agent.

Mirja Rotinen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 32793687